CAMERA2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial
Discussion
Key potential advantages of adding anti-staphylococcal β-lactams to standard therapy for MRSA bacteraemia include their safety profile, low cost, and wide availability.
Trial registration
ClinicalTrials.gov Identifier: NCT02365493. Registered 24 February 2015. (Source: Trials)
Source: Trials - March 30, 2016 Category: Research Source Type: clinical trials
IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB
Condition: BacteremiaInterventions: Drug: Daptomycin; Drug: Vancomycin; Drug: CeftarolineSponsor: Sharp HealthCareRecruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2015 Category: Research Source Type: clinical trials
The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock
Condition: Septic ShockInterventions: Drug: Daptomycin; Other: determination of plasma concentrationSponsor: Zhongda HospitalRecruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2015 Category: Research Source Type: clinical trials
